Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016

Introduction

Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016" provides an overview of Ischemic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Ischemic Cardiomyopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016

• Table of Contents

  Table of Contents 2

  List of Tables 3

  List of Figures 4

  Report Guidance 5

  Clinical Trials by Region 6

  Clinical Trials and Average Enrollment by Country 7

  Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

  Top Five Countries Contributing to Clinical Trials in Europe 10

  Top Countries Contributing to Clinical Trials in North America 11

  Top Countries Contributing to Clinical Trials in Middle East and Africa 12

  Top Countries Contributing to Clinical Trials in Central and South America 13

  Clinical Trials by G7 Countries: Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials 14

  Clinical Trials by Phase in G7 Countries 15

  Clinical Trials in G7 Countries by Trial Status 16

  Clinical Trials by E7 Countries: Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials 17

  Clinical Trials by Phase in E7 Countries 18

  Clinical Trials in E7 Countries by Trial Status 19

  Clinical Trials by Phase 20

  In Progress Trials by Phase 21

  Clinical Trials by Trial Status 22

  Clinical Trials by End Point Status 23

  Subjects Recruited Over a Period of Time 24

  Clinical Trials by Sponsor Type 25

  Prominent Sponsors 26

  Top Companies Participating in Ischemic Cardiomyopathy Therapeutics Clinical Trials 27

  Prominent Drugs 29

  Clinical Trial Profile Snapshots 30

  Appendix 73

  Abbreviations 73

  Definitions 73

  Research Methodology 74

  Secondary Research 74

  About GlobalData 75

  Contact Us 75

  Disclaimer 75

  Source 76

List Of Tables
in Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016

List of Tables

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2016* 6

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10

Ischemic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13

Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 14

Ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 17

Ischemic Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Ischemic Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2016* 20

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Ischemic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List Of Figures, Charts and Diagrams
in Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016

List of Figures

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10

Ischemic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12

Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 14

Ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 17

Ischemic Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Ischemic Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Ischemic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

GlobalData Methodology 74

Additional Details

Publisher

Global Data

Publisher Information

Reference

27194 | GDHC3599CTIDB

Number of Pages

76

Report Format

PDF

Related Reports